Industry Update: Dyne

Описание к видео Industry Update: Dyne

Defeat Duchenne Canada hosted an industry partner update recorded on Monday, July 8. In this free webinar, Dyne Therapeutics shared the latest clinical data from the DELIVER Trial of DYNE-251, an investigational medicine for Duchenne muscular dystrophy patients amenable to exon 51 skipping.

Discover the compelling impact on key disease biomarkers and trends in improvement of multiple functional endpoints. Stay informed and up to date with this critical information.

Hear more from our Industry Partners: https://defeatduchenne.ca/webinars/

Комментарии

Информация по комментариям в разработке

Похожие видео